Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Advanced Solid Tumors|Colorectal Cancer|Squamous Cell Head and Neck Cancer|Non Small Cell Lung Cancer|Triple Negative Breast Cancer
Interventions: DRUG: MM-151|DRUG: MM-151 + irinotecan
Sponsor: Merrimack Pharmaceuticals